MORRISVILLE, N.C.,— February 13, 2012—TearScience, a venture funded medical device company, today announced that its CEO and co-founder, Tim Willis, will be participating in a CEO panel discussion at the 21st annual CED Life Science Conference, to be held February 15-16, 2012, at the Raleigh Convention Center. This session, entitled “How to Survive in 2012 and Beyond,” will help entrepreneurs understand the various ways to grow their business including private financing, venture capital funding, initial public offering, partnerships, bringing ...
Read More →MORRISVILLE, N.C.,— February 1, 2012—TearScience, Inc., a privately-held medical device company, today announced that it has received U.S. Food and Drug Administration (FDA) clearance for its next generation product of its LipiFlow® Thermal Pulsation System , a medical device that treats evaporative dry eye by liquefying and evacuating obstructions in meibomian glands located in the eyelids. The second generation product includes a more robust graphical user interface and provides the ability for physicians to treat both of a ...
Read More →Patented LipiView® Ocular Surface Interferometer Helps Physicians Assess Dry Eye Patients
MORRISVILLE, N.C.,— January 3, 2012—TearScience, Inc., a venture funded medical device company, today announced it has been granted several patents on its LipiView® Ocular Surface Interferometer medical device. The LipiView® allows eye care physicians to assess the tear film of dry eye patients.
The LipiView® uses interferometric imaging to capture, manipulate, analyze, and store digital images of the tear film. TearScience’s patents (7,758,190; 7,988,294; and D614,774) cover ...
Read More →Herzig Eye Institute to Assist Eye Care Practices in Optimizing Implementation of Breakthrough Dry Eye Treatment
Morrisvile, N.C.,—December 5, 2011—TearScience, Inc., a privately-held medical device company, today announced Toronto-based Herzig Eye Institute, one of the leading authorities in laser vision correction and advanced cataract and refractive surgery, as its first Center of Excellence.
As a Center of Excellence, Herzig Eye Institute will educate eye care practices on how best to successfully implement TearScience’s LipiFlow® Thermal Pulsation System within a ...
Read More →TearScience’s LipiFlow Redefines Duke Eye Center’s Management of Dry Eye Patients
Durham, N.C.,— October 25, 2011—TearScience, Inc., a venture funded medical device company, today announced that Duke Eye Center, an academic research and education-based university eye care center, has purchased TearScience’s LipiFlow Thermal Pulsation System, a breakthrough treatment for evaporative dry eye disease and meibomian gland dysfunction. Duke Eye Center focuses on the latest technology, research, and education to provide the most advanced patient care, including ...
Read More →Carolina Vision Center Opens Dry Eye Clinic to Help Frustrated Dry Eye Patients
Morrisville, N.C.,— October 14, 2011—TearScience, Inc., a privately-held medical device company, today announced that Fayetteville, North Carolina-based Carolina Vision Center, is the first eye care center in United States to commercially offer the LipiFlow Thermal Pulsation System, a breakthrough treatment for evaporative dry eye disease. TearScience’s LipiFlow is designed to address meibomian gland dysfunction, allowing for the treatment of eyelid gland blockages during ...
Read More →MorrisvilLe, N.C.,—October 3, 2011—TearScience, Inc., a privately-held medical device company, today announced a $15M venture debt financing deal with Oxford Finance LLC and Silicon Valley Bank. The financing supports TearScience’s commercialization efforts of its new, innovative solution for evaluating the eye’s natural tear film and treating evaporative dry eye disease.
“We are pleased to engage Oxford Finance and Silicon Valley Bank as our newest partners supporting our commercialization efforts,” said Nicole Wicker, vice president of finance for TearScience. “Having ...
Read More →Morrisvile, N.C.,—August 15, 2011—TearScience, Inc., a privately-held medical device company, today announced that it has appointed Diethart Reichardt as senior vice president of the European region including Europe, Middle East and Africa. In this role, Reichardt will be responsible for sales, marketing, operations and customer service teams based in the European region as well as a distributor network in Africa and the Middle East. Reichardt will be based in Germany. TearScience’s advanced solutions are designed to help eye care physicians ...
Read More →TearScience to Begin Commercialization of LipiFlow In-office System in U.S.
MorrisvilLe, N.C.,—July 11, 2011—TearScience, Inc., a privately-held medical device company, today announced that it has received U.S. Food and Drug Administration (FDA) clearance for its LipiFlow Thermal Pulsation System for the treatment of meibomian gland dysfunction (MGD), also known as evaporative dry eye. The clearance enables TearScience to market and sell LipiFlow to eye care physicians in the U.S. LipiFlow will be available immediately, but on a limited basis ...
Read More →TearScience’s New System Offers Breakthrough Treatment for Dry Eye Patients
Morrisvile, N.C.,— June 13, 2011—TearScience, Inc., a privately-held medical device company, announced that the Toronto-based Herzig Eye Institute, one of the leading authorities in laser vision correction and advanced cataract and refractive surgery, is the first eye care centre in North America to introduce the innovative LipiFlow® evaporative dry eye disease treatment system, which has received a medical device licence from Health Canada.
Evaporative dry eye is caused by a deficiency ...
Read More →